Douglas Baum

Director/Board Member at Regent GLSC Technologies, Inc.

Net worth: 5 534 $ as of 30/04/2024

57 year

20 connections

Health Technology

Commercial Services

Electronic Technology

Active connections

Name	Gender	Age	Linked companies	Collaboration
David Arthur Nelson	M	76	Regent GLSC Technologies, Inc. Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007.	17 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Christopher Nelson	M	54	QSAM BIOSCIENCES, INC.	20 years
Steven Pieper	M	47	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	-
Kevin M. Bolin	M	60	QSAM BIOSCIENCES, INC.	4 years
Namrata Chand	F	43	QSAM BIOSCIENCES, INC.	-
Paul Edick	M	67	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	-
Adriann Sax	F	63	QSAM BIOSCIENCES, INC.	2 years
Adam King	M	39	QSAM BIOSCIENCES, INC.	3 years
Scott W. Whitney	M	67	QSAM BIOSCIENCES, INC.	5 years
Tristan Anthony Peitz	M	40	QSAM BIOSCIENCES, INC.	3 years
Jeffrey Soinski	M	61	QSAM BIOSCIENCES, INC.	-
C. Piazza	M	77	QSAM BIOSCIENCES, INC.	20 years
Joel D. Mayersohn	M	66	QSAM BIOSCIENCES, INC.	8 years
Jonathan Rigby	M	56	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	3 years
Charles Link	M	64	QSAM BIOSCIENCES, INC.	3 years
Michelle Murcia	F	56	QSAM BIOSCIENCES, INC.	3 years
Arthur W. Batson	M	64	QSAM BIOSCIENCES, INC.	-
David Shields	M	-	QSAM BIOSCIENCES, INC.	-
Sudheer M. Pimputkar	M	74	QSAM BIOSCIENCES, INC.	1 years
Christopher J. Spencer	M	55	QSAM BIOSCIENCES, INC.	2 years

Statistics

Country	Connections	% of total
United States	20	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections